| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.78B | 3.20B | 2.99B | 3.08B | 2.72B | 1.91B |
| Gross Profit | 919.00M | 985.50M | 1.10B | 875.90M | 794.20M | 692.90M |
| EBITDA | 1.41B | 1.77B | 334.80M | 1.84B | 1.68B | 922.30M |
| Net Income | -194.10M | -128.50M | -93.50M | -300.00K | 11.10M | -19.60M |
Balance Sheet | ||||||
| Total Assets | 5.16B | 5.12B | 5.10B | 4.41B | 4.33B | 3.69B |
| Cash, Cash Equivalents and Short-Term Investments | 202.40M | 205.70M | 277.00M | 210.90M | 256.90M | 361.30M |
| Total Debt | 3.89B | 3.66B | 3.72B | 3.18B | 2.76B | 2.35B |
| Total Liabilities | 6.28B | 6.04B | 6.13B | 4.85B | 4.26B | 3.71B |
| Stockholders Equity | -1.26B | -1.05B | -1.15B | -780.40M | -261.30M | -236.90M |
Cash Flow | ||||||
| Free Cash Flow | -53.70M | -120.30M | 479.00M | 339.60M | -441.10M | -242.60M |
| Operating Cash Flow | -42.10M | -106.80M | 488.90M | 346.10M | -435.00M | -232.40M |
| Investing Cash Flow | -7.40M | -35.40M | -331.80M | 31.30M | -180.70M | -300.00K |
| Financing Cash Flow | 52.40M | 84.50M | -74.90M | -394.50M | 525.50M | 365.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $30.83B | 16.45 | 17.33% | 0.75% | 14.91% | 9.30% | |
75 Outperform | $202.68B | 16.58 | 11.78% | 1.10% | 3.61% | 152.34% | |
71 Outperform | $404.63B | 36.99 | 42.86% | ― | 15.49% | 35.54% | |
68 Neutral | $70.96B | 152.61 | 1.36% | ― | -4.29% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
52 Neutral | $2.60B | -12.95 | ― | ― | 97.19% | -21.46% | |
51 Neutral | $13.33B | -46.30 | -1.90% | 1.48% | -0.48% | 97.09% |
Lionsgate Studios Corp. has scheduled its initial annual general and special meeting of shareholders for March 17, 2026, to be held at its Canadian head office, with further details to be provided in a forthcoming proxy statement. The company has established January 20, 2026, as the deadline for shareholder proposals to be included in the proxy materials under Rule 14a-8, and February 13, 2026, as the cutoff for eligible shareholders to submit director nominations, reinforcing formal governance processes and providing a clear timetable for investor participation in corporate decision-making.
The most recent analyst rating on (LION) stock is a Buy with a $11.00 price target. To see the full list of analyst forecasts on Lionsgate Studios stock, see the LION Stock Forecast page.